Jiann-Her Lin1, Li-Nien Chien2, Wan-Ling Tsai3, Li-Ying Chen4, Yung-Hsiao Chiang1, Yi-Chen Hsieh5. 1. The PhD Program for Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan; Department of Neurosurgery, Taipei Medical University Hospital, Taipei 11031, Taiwan; Division of Neurosurgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan. 2. School of Health Care Administration, College of Management, Taipei Medical University, Taipei 11031, Taiwan. 3. The PhD Program for Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan; Department of Neurosurgery, Taipei Medical University Hospital, Taipei 11031, Taiwan; Graduate Institute of Injury Prevention and Control, College of Public Health and Nutrition, Taipei Medical University, Taipei 11031, Taiwan. 4. Health and Clinical Research Center, College of Public Health and Nutrition, Taipei Medical University, Taipei 11031, Taiwan. 5. The PhD Program for Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan; Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan. Electronic address: ychsieh@tmu.edu.tw.
Abstract
BACKGROUND CONTEXT: Whether early vertebroplasty (VP) (within 3 months) offers extra benefit to aged patients older than 70 years with painful vertebral compression fractures (PVCF) in terms of mortality and respiratory-related morbidity remains unknown, given that the elderly is associated with higher surgical risks. PURPOSE: To elucidate the benefits of an early VP intervention for aged patients with a PVCF by comparing the risks of mortality and respiratory-related morbidity. STUDY DESIGN: A retrospective propensity score matched cohort. PATIENT SAMPLE: PVCF patients with an early VP and without an early VP intervention. OUTCOME MEASURES: Death, pneumonia, and respiratory failure. METHODS: A total of 10,785 PVCF patients who used analgesic injection during admission from 2000 through 2013 were selected from the National Health Insurance Research Database in Taiwan. After matching, there were 1773 VP patients and 5324 non-VP patients included in this study. Conditional Cox proportional hazard models were used to determine the risk of death and respiratory complications. RESULTS: The incidences of death at 1 year of VP and non-VP patients were 0.46 (95% confidence interval [CI]: 0.38-0.56) and 0.63 (95% CI: 0.57-0.70) per 100 person-months, respectively. We observed a hazard ratio (HR) of 1.39 (95% CI: 1.09-1.78, p=.008) when comparing non-VP to VP patients. This phenomenon was seen when estimating the benefits of respiratory failure (HR: 1.46; 95% CI: 1.04-2.05, p=.028). CONCLUSION: The results showed that VP was associated with lower risks of mortality and respiratory failure in aged patients with a PVCF. VP should be considered a priority for the aged patients with a PVCF requiring admission and analgesics.
BACKGROUND CONTEXT: Whether early vertebroplasty (VP) (within 3 months) offers extra benefit to aged patients older than 70 years with painful vertebral compression fractures (PVCF) in terms of mortality and respiratory-related morbidity remains unknown, given that the elderly is associated with higher surgical risks. PURPOSE: To elucidate the benefits of an early VP intervention for aged patients with a PVCF by comparing the risks of mortality and respiratory-related morbidity. STUDY DESIGN: A retrospective propensity score matched cohort. PATIENT SAMPLE: PVCF patients with an early VP and without an early VP intervention. OUTCOME MEASURES: Death, pneumonia, and respiratory failure. METHODS: A total of 10,785 PVCF patients who used analgesic injection during admission from 2000 through 2013 were selected from the National Health Insurance Research Database in Taiwan. After matching, there were 1773 VP patients and 5324 non-VP patients included in this study. Conditional Cox proportional hazard models were used to determine the risk of death and respiratory complications. RESULTS: The incidences of death at 1 year of VP and non-VP patients were 0.46 (95% confidence interval [CI]: 0.38-0.56) and 0.63 (95% CI: 0.57-0.70) per 100 person-months, respectively. We observed a hazard ratio (HR) of 1.39 (95% CI: 1.09-1.78, p=.008) when comparing non-VP to VP patients. This phenomenon was seen when estimating the benefits of respiratory failure (HR: 1.46; 95% CI: 1.04-2.05, p=.028). CONCLUSION: The results showed that VP was associated with lower risks of mortality and respiratory failure in aged patients with a PVCF. VP should be considered a priority for the aged patients with a PVCF requiring admission and analgesics.
Keywords:
Mortality; National Health Insurance Research Database; Painful vertebral compression fracture; Respiratory failure; The elderly; Vertebroplasty